Boston Scientific (NYSE: BSX) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.83 by 3.61 percent. This is a 14.67 percent increase over earnings of $0.75 per share from the same period last year. The company reported quarterly sales of $5.442 billion which beat the analyst consensus estimate of $5.361 billion by 1.52 percent. This is a 7.53 percent increase over sales of $5.061 billion the same period last year.